UroGen Pharma Ltd. Annual Return On Equity in % from 2017 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
UroGen Pharma Ltd. quarterly/annual Return On Equity history and growth rate from 2017 to 2023.
  • UroGen Pharma Ltd. Return On Equity for the quarter ending September 30, 2024 was 932 %, a 757% increase year-over-year.
  • UroGen Pharma Ltd. annual Return On Equity for 2023 was 113 %, a 45.8% decline from 2022.
  • UroGen Pharma Ltd. annual Return On Equity for 2022 was 208 %.
  • UroGen Pharma Ltd. annual Return On Equity for 2021 was -257 %, a 155% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 113 -95.6 -45.8% Jan 1, 2023 Dec 31, 2023
2022 208 +465 Jan 1, 2022 Dec 31, 2022
2021 -257 -156 -155% Jan 1, 2021 Dec 31, 2021
2020 -101 -51.6 -105% Jan 1, 2020 Dec 31, 2020
2019 -49.2 +21 +30% Jan 1, 2019 Dec 31, 2019
2018 -70.2 -35.7 -104% Jan 1, 2018 Dec 31, 2018
2017 -34.5 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.